Literature DB >> 8823300

Gene mapping of familial autosomal dominant dilated cardiomyopathy to chromosome 10q21-23.

K R Bowles1, R Gajarski, P Porter, V Goytia, L Bachinski, R Roberts, R Pignatelli, J A Towbin.   

Abstract

Dilated cardiomyopathy (DCM) is the most common form of primary myocardial disorder, accounting for 60% of all cardiomyopathies. In 20-30% of cases, familial inheritance can be demonstrated; an autosomal dominant transmission is the usual type of inheritance pattern identified. Previously, genetic heterogeneity was demonstrated in familial autosomal dominant dilated cardiomyopathy (FDCM). Gene localization to chromosome 1 (1p1-1q1 and 1q32), chromosome 3 (3p25-3p22), and chromosome 9 (9q13-9q22) has recently been identified. We report one family with 26 members (12 affected) with familial autosomal dominant dilated cardiomyopathy in which linkage to chromosome 10 at the 10q21-q23 locus is identified. Using short tandem repeat polymorphism (STR) markers with heterozygosity > 70%, 169 markers (50% of the genome) were used before linkage was found to markers D10S605 and D10S201 with a pairwise LOD score = 3.91, theta = 0, penetrance = 100% for both markers. Linkage to 1p1-1q1, 1q32, 3p25-3p22, and 9q13-9q22 was excluded. We conclude that a new locus for pure autosomal dominant FDCM exists, and that this gene is localized to a 9 cM region of 10q21-10q23. The search for the disease causing gene and the responsible mutation(s) is ongoing.

Entities:  

Mesh:

Year:  1996        PMID: 8823300      PMCID: PMC507561          DOI: 10.1172/JCI118922

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  56 in total

1.  Complete sequence of human vinculin and assignment of the gene to chromosome 10.

Authors:  P A Weller; E P Ogryzko; E B Corben; N I Zhidkova; B Patel; G J Price; N K Spurr; V E Koteliansky; D R Critchley
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

2.  A routine method for the establishment of permanent growing lymphoblastoid cell lines.

Authors:  H Neitzel
Journal:  Hum Genet       Date:  1986-08       Impact factor: 4.132

Review 3.  The syndrome of papillary muscle dysfunction.

Authors:  G E Burch; N P DePasquale; J H Phillips
Journal:  Am Heart J       Date:  1968-03       Impact factor: 4.749

4.  Echocardiographic measurements in normal subjects from infancy to old age.

Authors:  W L Henry; J M Gardin; J H Ware
Journal:  Circulation       Date:  1980-11       Impact factor: 29.690

5.  Prevalence of clinical mitral-valve prolapse in 1169 young women.

Authors:  P M Procacci; S V Savran; S L Schreiter; A L Bryson
Journal:  N Engl J Med       Date:  1976-05-13       Impact factor: 91.245

6.  Mitral valve prolapse in one hundred presumably healthy young females.

Authors:  W Markiewicz; J Stoner; E London; S A Hunt; R L Popp
Journal:  Circulation       Date:  1976-03       Impact factor: 29.690

7.  Mitral valve prolapse syndrome in children with Duchenne's progressive muscular dystrophy.

Authors:  S K Sanyal; R K Leung; R C Tierney; R Gilmartin; S Pitner
Journal:  Pediatrics       Date:  1979-01       Impact factor: 7.124

8.  Strategies for multilocus linkage analysis in humans.

Authors:  G M Lathrop; J M Lalouel; C Julier; J Ott
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

9.  Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy. A population-based study in Olmsted County, Minnesota, 1975-1984.

Authors:  M B Codd; D D Sugrue; B J Gersh; L J Melton
Journal:  Circulation       Date:  1989-09       Impact factor: 29.690

10.  Familial hypertrophic cardiomyopathy is a genetically heterogeneous disease.

Authors:  S D Solomon; J A Jarcho; W McKenna; A Geisterfer-Lowrance; R Germain; R Salerni; J G Seidman; C E Seidman
Journal:  J Clin Invest       Date:  1990-09       Impact factor: 14.808

View more
  24 in total

Review 1.  Many roads lead to a broken heart: the genetics of dilated cardiomyopathy.

Authors:  J Schönberger; C E Seidman
Journal:  Am J Hum Genet       Date:  2001-07-06       Impact factor: 11.025

2.  Congenital semilunar valvulogenesis defect in mice deficient in phospholipase C epsilon.

Authors:  Makoto Tadano; Hironori Edamatsu; Susumu Minamisawa; Utako Yokoyama; Yoshihiro Ishikawa; Noboru Suzuki; Hiromitsu Saito; Dongmei Wu; Misa Masago-Toda; Yuriko Yamawaki-Kataoka; Tomiyoshi Setsu; Toshio Terashima; Sakan Maeda; Takaya Satoh; Tohru Kataoka
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

3.  A novel locus for autosomal-dominant dilated cardiomyopathy maps to chromosome 7q22.3-31.1.

Authors:  Jost Schönberger; Leif Kühler; Elisabete Martins; Tom H Lindner; Jose Silva-Cardoso; Michael Zimmer
Journal:  Hum Genet       Date:  2005-10-14       Impact factor: 4.132

Review 4.  The genomics of cardiovascular disorders: therapeutic implications.

Authors:  P Ferrari; G Bianchi
Journal:  Drugs       Date:  2000-05       Impact factor: 9.546

Review 5.  [Genetics of dilated cardiomyopathy].

Authors:  L Thierfelder
Journal:  Med Klin (Munich)       Date:  1998-04-15

6.  [Classification of cardiomyopathies according to the WHO/ISFC Task Force--more questions than answers?].

Authors:  B Maisch
Journal:  Med Klin (Munich)       Date:  1998-04-15

Review 7.  Monogenic atrial fibrillation as pathophysiological paradigms.

Authors:  Saagar Mahida; Steven A Lubitz; Michiel Rienstra; David J Milan; Patrick T Ellinor
Journal:  Cardiovasc Res       Date:  2010-11-30       Impact factor: 10.787

8.  Genetic Counseling and Screening Issues in Familial Dilated Cardiomyopathy.

Authors:  E L Hanson; R E Hershberger
Journal:  J Genet Couns       Date:  2001-10       Impact factor: 2.537

Review 9.  [Genetics of atrial fibrillation: rare mutations, common variants and clinical relevance?].

Authors:  M F Sinner; A Pfeufer; S Kääb
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2006-06

Review 10.  Mendelian forms of structural cardiovascular disease.

Authors:  Calum A MacRae
Journal:  Curr Cardiol Rep       Date:  2013-10       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.